Kiffer Carlos R, Mendes Caio, Oplustil Carmen P, Sampaio Jorge L
Section of Microbiology, Fleury Institute, Sao Paulo, SP, Brazil.
Int Braz J Urol. 2007 Jan-Feb;33(1):42-8; discussion 49. doi: 10.1590/s1677-55382007000100007.
We assessed the antimicrobial resistance patterns of pathogens responsible for urinary tract infections (UTI) in outpatients in São Paulo, Brazil, as well as the Escherichia coli antimicrobial resistance trend.
Outpatients urine cultures were collected from January 2000 to December 2003. Statistical analysis considered positive results for one bacterial species with colony count >or= 100,000 CFU/mL. Stratification was done on age group and gender. Statistical tests used included chi-square and the chi-square test for trend to evaluate differences between susceptibility rates among age groups and ordering in the E. coli resistance rates per year, respectively.
There were 37,261 positive results with Enterobacteriaceae isolated in 32,530 (87.3%) and Gram-positive cocci in 2,570 (6.9%) cultures. E. coli had the highest prevalence (71.6%). Susceptibility tests were performed in 31,716 cultures. E. coli had elevated resistance rates (> 30%) to ampicillin, trimethoprim-sulfamethoxazole, and tetracycline. Significant differences between age groups and ordering among years were observed.
The use of trimethoprim-sulfamethoxazole is precluded in the population studied due to elevated resistance rates (> 30%) among most prevalent pathogens. Significant resistance rate differences among age groups and years were observed, particularly for fluoroquinolones. Fluoroquinolones should be used with caution. Nitrofurantoin should be used as empirical therapy for primary, non-complicated urinary tract infections.
我们评估了巴西圣保罗门诊患者中引起尿路感染(UTI)的病原体的抗菌药物耐药模式,以及大肠杆菌的抗菌药物耐药趋势。
收集2000年1月至2003年12月门诊患者的尿液培养物。统计分析考虑菌落计数≥100,000 CFU/mL的一种细菌的阳性结果。按年龄组和性别进行分层。使用的统计检验包括卡方检验和趋势卡方检验,分别用于评估年龄组之间药敏率的差异以及每年大肠杆菌耐药率的排序。
共获得37,261份阳性结果,其中肠杆菌科细菌在32,530份(87.3%)培养物中分离得到,革兰氏阳性球菌在2,570份(6.9%)培养物中分离得到。大肠杆菌的患病率最高(71.6%)。对31,716份培养物进行了药敏试验。大肠杆菌对氨苄西林、甲氧苄啶 - 磺胺甲恶唑和四环素的耐药率升高(>30%)。观察到年龄组之间存在显著差异以及各年份之间的排序差异。
在所研究的人群中,由于大多数常见病原体的耐药率升高(>30%),不建议使用甲氧苄啶 - 磺胺甲恶唑。观察到年龄组和年份之间存在显著的耐药率差异,尤其是氟喹诺酮类。应谨慎使用氟喹诺酮类。呋喃妥因应用于原发性非复杂性尿路感染的经验性治疗。